Measles is highly contagious among those who are unvaccinated and may have severe health consequences in children under age 5 years.

Physical activity levels have a significant association with a reduced incidence of restrictive spirometry patterns (RSP).

Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in adolescents aged 13 to 17 years.

The FDA has approved Emrelis for the treatment of adult patients with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

Increasing antibiotic treatment adherence among children lowered average treatment durations by up to 1.7 days.

Novo Nordisk has contracted California-based biotech Septerna to develop oral pills that target G protein-coupled receptors.